Corinne Johnson

Stock Analyst at Goldman Sachs

(1.37)

# 2,830

Out of 4,479 analysts

5

Total ratings

66.67%

Success rate

3.91%

Average return

Main Sectors:

Top Industries:

3 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Upgrades: Buy	$43 → $50	$31.32	+59.64%	3	May 14, 2024
	IMVT Immunovant	Initiates: Buy	$50	$26.52	+88.54%	1	Mar 13, 2024
	AVBP ArriVent BioPharma	Initiates: Buy	$27	$18.41	+46.66%	1	Feb 20, 2024

CG Oncology

May 14, 2024

Upgrades: Buy

Price Target: $43 → $50

Current: $31.32

Upside: +59.64%

Immunovant

Mar 13, 2024

Initiates: Buy

Price Target: $50

Current: $26.52

Upside: +88.54%

ArriVent BioPharma

Feb 20, 2024

Initiates: Buy

Price Target: $27

Current: $18.41

Upside: +46.66%